BMS-986435 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-07-03 in 11d
ESTIMATED |
READOUT
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in
Phase 2 · Heart Failure |
BMY BRISTOL MYERS SQUIBB CO | BMS-986435 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
|